Vibeg 75 mg is a Product of the Generic Vibegron

Vibeg 75 mg belongs to the generic category of Vibegron. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Vibeg 75 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Vibegron and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Vibeg 75 mg

Vibeg 75 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Vibeg 75 mg is provided below to help users gain a clear understanding of this medicine.

What Is Vibeg 75 mg Indications and Uses?

Vibeg 75 mg (Vibegron) is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

Pharmacology (Source, Chemical and Physical Composition) Of Vibeg 75 mg

Vibeg 75 mg (Vibegron) is a potent, selective beta-3 adrenergic receptor agonist that relaxes the detrusor smooth muscle of the bladder, thereby increasing bladder capacity.

Dosage And Administration of Vibeg 75 mg

The recommended dosage of Vibeg 75 mg (Vibegron) is one 75 mg tablet orally, once daily with or without food. Use in Children: Safety and effectiveness of Vibegron in pediatric patients have not been established.

Drug Interactions of Vibeg 75 mg

Concomitant use of Vibeg 75 mg (Vibegron) increases digoxin maximal concentrations (Cmax) and systemic exposure as assessed by area under the concentration-time curve (AUC). Serum digoxin concentrations should be monitored before initiating and during therapy with Vibeg and used for titration of the digoxin dose to obtain the desired clinical effect. Continue monitoring digoxin concentrations upon discontinuation of Vibeg and adjust digoxin dose as needed.

Side Effects of Vibeg 75 mg

The most common adverse reactions of Vibeg 75 mg (Vibegron) include: Urinary tract infection, nasal congestion, sore throat or runny nose, nausea, headache, diarrhea, upper respiratory tract infection.

Precautions And Warnings for Vibeg 75 mg

Urinary retention has been reported in patients taking Vibeg 75 mg (Vibegron). Discontinue Vibeg in patients who develop urinary retention.

Use During Pregnancy and Lactation

There are no available data on Vibeg 75 mg (Vibegron) use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are no data on the presence of Vibegron in human milk, the effects of the drug on the breastfed infant, or the effects on milk production.

Therapeutic Class

β₃-adrenergic receptor agonist

Storage Conditions of It

Store below 30⁰C in a dry place, protect from light. Keep out of reach of children. Pack Image: Vibeg 75 mg Tablet Thanks for using MedEx! How would you rate your experience so far?

Vibeg 75 mg is a Product of the Generic Vibegron

Vibeg 75 mg

UniMed UniHealth Pharmaceuticals Ltd. · Tablet

Vibegron